FDA+ channel feed – Endpoints News

FDA+ channel feed

Republicans pressure FDA on foreign inspections, threaten subpoena

Last year

FDA approves high-risk neuroblastoma treatment for kids and adults

Last year

Sanofi and AstraZeneca to make 230,000 additional RSV immunizations available, White House says

Last year

White House keeps focus on lowering drug prices, turns Regeneron's contract language into new standard

Last year

FDA puts three CARsgen CAR-T therapies on clinical hold, including Moderna-partnered program

Last year

Senate health committee advances changes to how FDA would approve new opioids

Last year

House passes sweeping healthcare price transparency reforms, reining in PBM practices

Last year

FDA establishes new advisory committee for genetic metabolic disease treatments

Last year

FDA rolls out new draft guidance on advanced manufacturing tech

Last year

FDA sets late 2024 decision deadline for Pfizer’s 'pan-hemophilia' drug: #ASH23

Last year

Bipartisan House bill seeks to boost pediatric drug development via new FDA penalties for noncompliance

Last year

ICER unveils latest report on 'unsupported' drug price increases

Last year

FDA approves two gene therapies for sickle cell disease, including first that uses CRISPR

Last year

Biden proposal on 'march-in' rights would have limited effect on current drug costs, critics say

Last year

House committee advances key PBM bills in step with Senate counterparts

Last year

Biden administration lays foundation for use of march-in rights as it talks up drug price goals

Last year

FDA asks for more data from Optinose, extends review time for nasal spray

Last year

Pfizer plans to pull out of BIO, following moves by other large drugmakers to reduce lobbying footprint

Last year

FDA approves Novartis drug for rare blood disorder

Last year

FDA sends letter to Novartis over Kymriah manufacturing safety concerns

Last year

The politics behind drug shortages: Senators talk issues with generics market, CMS payments

Last year

Roche's BTK inhibitor put on partial hold over concerns about potential liver injury

Last year

House committee investigates FDA’s handling of common nasal decongestant as efficacy questions loom

Last year

FDA approves Lilly’s BTK inhibitor Jaypirca for two more blood cancers

Last year

First page Previous page 35 36 373839 40 41 Next page Last page